The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Three women and three girls were reportedly shot dead because they were trailing 100 metres behind IS fighters.
Building a third runway at Heathrow was the most controversial of the three expansion options, so why is it going ahead?
The body of toddler Norma Dale was found dumped on wasteland near her home in 1946 with one of her red shoes missing.